Results 1 - 10 of 17

< 1 2 >

• Deciphering the biodiversity of Listeria monocytogenes lineage III strains by polyphasic approaches, The Journal of Microbiology

  [DOI: 10.1007/s12275-011-1006-4]
  
• The Pharmacology and Clinical Use of the Antidepressants Vilazodone, Levomilnacipran, and Vortioxetine for Depression in the Elderly, Current Geriatrics Reports

  [DOI: 10.1007/s13670-015-0140-y]
  
• Antidepressants, Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents

  [DOI: 10.1007/978-3-319-27883-4_9]
  
• The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, CNS Drugs

  [DOI: 10.1007/s40263-016-0334-7]
  
• Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects, Clinical Drug Investigation

  [DOI: 10.1007/s40261-015-0318-2]
  
• Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to trials using traditional semi-structured interviews, Psychopharmacology

  [DOI: 10.1007/s00213-014-3584-4]
  
• Drugs in Clinical Development for Major Depressive Disorder, Pharmaceutical Medicine

  [DOI: 10.1007/s40290-013-0007-5]
  
• Levomilnacipran Extended Release: First Global Approval, Drugs

  [DOI: 10.1007/s40265-013-0116-1]
  
• Effect of Hepatic Impairment on the Pharmacokinetics of Levomilnacipran Following a Single Oral Dose of a Levomilnacipran Extended-Release Capsule in Human Participants, Clinical Drug Investigation

  [DOI: 10.1007/s40261-014-0182-5]
  
• Levomilnacipran Extended-Release: A Review of Its Use in Adult Patients with Major Depressive Disorder, CNS Drugs

  [DOI: 10.1007/s40263-014-0203-1]